Finance

Lists
Why is OPK up ३.४४%?
Dive Deeper
OPK:NASDAQ
OPKO Health Inc
US$ १.६६
+३.४४%
(+०.०५५) 1D
अक्टोबर २२, १५:०५:५८ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OPK...
Open
US$ १.६०
High
US$ १.६७
Low
US$ १.५८
Mkt. cap
१.२४ अरब
Avg. vol.
४४.२९ लाख
Volume
१३.२३ लाख
52-wk high
US$ १.७७
52-wk low
US$ ०.९८
EPS
-US$ ०.१०
Beta
१.५१
Shares outstanding
७४.६३ करोड
No. of employees
२ हजार
Open
US$ १.६०
High
US$ १.६७
Low
US$ १.५८
Mkt. cap
१.२४ अरब
Avg. vol.
४४.२९ लाख
Volume
१३.२३ लाख
52-wk high
US$ १.७७
52-wk low
US$ ०.९८
EPS
-US$ ०.१०
Beta
१.५१
Shares outstanding
७४.६३ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
About OPKO Health Inc
CEO-
Employees२.२८ हजार
Founded१९९१
Headquartersमायामी, फ्लोरिडा, संयुक्त राज्य अमेरिका
Sector-
Websiteopko.com
Analyst ratings
Based on 3 analysts giving stock ratings to OPK in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OPK in the last 3 months.
Highest
Current US$ १.६६
US$ ४.०० (+१४१.६९%)
Average
US$ ३.०८ (+८६.१०%)
Lowest
US$ २.२५ (+३५.९५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Buy
Upgraded
US$ २.२५
+३६%
10/16/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
US$ ४.००
+१४१.७%
10/16/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$ ३.००
+८१.३%
10/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
US$ ३.००
+८१.३%
02/27/2026
Next call ६ दिनमा
अक्टोबर २८, बुध, २२:३०
Fiscal period
Q3 2026
- / -US$ ०.०६
Revenue / Est. (USD)
- / १३.६६ करोड
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१५.१७ करोड
१४.८४ करोड
१२.४२ करोड
१६.३६ करोड
Cost of goods sold
१३.१९ करोड
११.७२ करोड
१०.७६ करोड
११.६७ करोड
Cost of revenue
१३.१९ करोड
११.७२ करोड
१०.७६ करोड
११.६७ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५.३८ करोड
५.५२ करोड
४.८६ करोड
५.२९ करोड
Operating expense
७.३३ करोड
७.४३ करोड
६.७६ करोड
७.१९ करोड
Total operating expenses
२०.५२ करोड
१९.१५ करोड
१७.५२ करोड
१८.८६ करोड
Operating income
-५.३५ करोड
-४.३० करोड
-५.१० करोड
-२.५० करोड
Other non operating income
६.१० लाख
-३.५४ लाख
१.३९ लाख
१६.३२ लाख
EBT including unusual items
४.१४ करोड
-४.६९ करोड
-६.१० करोड
-१.३४ करोड
EBT excluding unusual items
-६.०१ करोड
-५.१४ करोड
-५.७३ करोड
-३.१५ करोड
Income tax expense
१.९८ करोड
-१.५७ करोड
-६१.१० लाख
-४९.८३ लाख
Effective tax rate
४७.७९%
३३.३८%
१०.०२%
३७.१९%
Other operating expenses
-
-
-
-
Net income
२.१६ करोड
-३.१३ करोड
-५.४८ करोड
-८४.१६ लाख
Net profit margin
१४.२६%
-२१.०६%
-४४.१६%
-५.१४%
Earnings per share
-
-०.०४
-
-०.०३
Interest and investment income
३०.२३ लाख
३८.२० लाख
३०.०७ लाख
३२.२१ लाख
Interest expense
-१.१४ करोड
-१.१३ करोड
-१.०९ करोड
-१.१४ करोड
Net interest expenses
-८३.३५ लाख
-७४.९० लाख
-७९.३२ लाख
-८१.५९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३.०८ करोड
-२.०६ करोड
-२.८८ करोड
-२६.३४ लाख
Gain or loss from assets sale
-१०.१६ करोड
६.०१ लाख
-३४.०० हजार
-१.७९ करोड
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू